MedCity News September 5, 2024
Stephanie Baum

Dr. Tina Saw is the founder and CEO of Oral Genome, a healthcare startup that’s developing saliva tests to detect and prevent oral diseases. In response to emailed questions, Saw talked about her company’s approach.

For years, clinical studies have shown a correlation between things like gum disease and chronic conditions such as cardiovascular disease. Oral Genome, a member of the Health Wildcatters accelerator, is a healthcare startup that’s developing saliva tests to detect and prevent oral diseases. In response to emailed questions, Saw talked about her company’s approach.

Why did you start this company?

I started Oral Genome to address a significant gap in the early detection and prevention of oral diseases, particularly focusing on how these diseases are...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Interview / Q&A, Provider, Trends
Dexcom Adds Generative AI Platform to Its Over-the-Counter CGM
Happy Holidays: Is Your Doctor Happy? Are You Happy With Your Doctor?
How AI Is Quietly Transforming E-Commerce Search And Discovery
Telehealth gets short extension, physician pay is cut in spending bill
Google Care Studio: Improving Patient Outcomes

Share This Article